{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:33:36Z","timestamp":1787319216581,"version":"build-2736575974"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,27]]},"DOI":"10.1093\/cvr\/cvad180","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T01:53:20Z","timestamp":1701914000000},"page":"1-2","source":"Crossref","is-referenced-by-count":10,"title":["Tumour necrosis factor-\u03b1 in cardiac inflammation: friend or foe?"],"prefix":"10.1093","volume":"120","author":[{"given":"Daniel","family":"Harding","sequence":"first","affiliation":[{"name":"Faculty of Medicine and Dentistry, William Harvey Research Institute, Barts and The London SMD, Queen Mary University of London, Charterhouse Square , London EC1M 6BQ , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Fanti","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, William Harvey Research Institute, Barts and The London SMD, Queen Mary University of London, Charterhouse Square , London EC1M 6BQ , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8747-5823","authenticated-orcid":false,"given":"Federica","family":"Marelli-Berg","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Dentistry, William Harvey Research Institute, Barts and The London SMD, Queen Mary University of London, Charterhouse Square , London EC1M 6BQ , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"2024022722273412100_cvad180-B1","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"2024022722273412100_cvad180-B2","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","article-title":"Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"2024022722273412100_cvad180-B3","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/modpathol.3800158","article-title":"Overexpression of tumor necrosis factor (TNF)\u03b1 and TNF\u03b1 receptor I in human viral myocarditis: clinicopathologic correlations","volume":"17","author":"Calabrese","year":"2004","journal-title":"Mod Pathol"},{"key":"2024022722273412100_cvad180-B4","doi-asserted-by":"crossref","first-page":"922782","DOI":"10.3389\/fimmu.2022.922782","article-title":"TNF-\u03b1 Inhibitors and other biologic agents for the treatment of immune checkpoint inhibitor-induced myocarditis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"2024022722273412100_cvad180-B5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ahj.2008.02.025","article-title":"Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis","volume":"156","author":"Setoguchi","year":"2008","journal-title":"Am Heart J"},{"key":"2024022722273412100_cvad180-B6","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/archdermatol.2012.2502","article-title":"Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis","volume":"148","author":"Wu","year":"2012","journal-title":"Arch Dermatol"},{"key":"2024022722273412100_cvad180-B7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/annrheumdis-2016-209784","article-title":"Extended report: relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis","volume":"76","author":"Low","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2024022722273412100_cvad180-B8","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/heartjnl-2013-303648","article-title":"Cardiovascular effects of tumour necrosis factor \u03b1 antagonism in patients with acute myocardial infarction: a first in human study","volume":"99","author":"Padfield","year":"2013","journal-title":"Heart"},{"key":"2024022722273412100_cvad180-B9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/cvr\/cvad158","article-title":"TNF-\u03b1 protects from exacerbated myocarditis and cardiac death by suppressing expansion of activated heart-reactive CD4+ T cells","volume":"120","author":"Rolski","year":"2024","journal-title":"Cardiovasc Res"},{"key":"2024022722273412100_cvad180-B10","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.3390\/jcm9103267","article-title":"Complexity of TNF-\u03b1 signaling in heart disease","volume":"9","author":"Rolski","year":"2020","journal-title":"J Clin Med"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvad180\/55049107\/cvad180.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/1\/1\/56773628\/cvad180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/120\/1\/1\/56773628\/cvad180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T07:35:05Z","timestamp":1730792105000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/120\/1\/1\/7460387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,7]]},"published-print":{"date-parts":[[2024,2,27]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvad180","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,12,7]]}}}